BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28029307)

  • 41. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors.
    Varshney VK; Gupta RK; Saluja SS; Tyagi I; Mishra PK; Batra VV
    Indian J Cancer; 2019; 56(2):135-143. PubMed ID: 31062732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.
    Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
    Reichardt P; Reichardt A
    Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature.
    Hechtman JF; DeMatteo R; Nafa K; Chi P; Arcila ME; Dogan S; Oultache A; Chen W; Hameed M
    Ann Surg Oncol; 2015 Aug; 22(8):2633-9. PubMed ID: 25564173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
    Tsyganova IV; Anurova OA; Mazurenko NN
    Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
    Patil DT; Rubin BP
    Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Management of Germline Gastrointestinal Stromal Tumor.
    Kwak HV; Tardy KJ; Allbee A; Stashek K; DeMatteo RP
    Ann Surg Oncol; 2023 Aug; 30(8):4966-4974. PubMed ID: 37115371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastatic SDH-Deficient GIST Diagnosed during Pregnancy: Approach to a Complex Case.
    Chennouf A; Zeidan E; Borduas M; Noël-Lamy M; Kremastiotis J; Beaudoin A
    Curr Oncol; 2022 Aug; 29(8):5933-5941. PubMed ID: 36005206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
    J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
    Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY
    Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship of c-kit and platelet-derived growth factor receptor alpha gene mutation features with prognosis of patients with gastrointestinal stromal tumor].
    Li CY; Liang XB; Ma JJ; Jiang HY; Hu XZ; Yan D; Hou SH; Wang LP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):271-5. PubMed ID: 22454176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms.
    Chan CH; Cools-Lartigue J; Marcus VA; Feldman LS; Ferri LE
    Can J Surg; 2012 Dec; 55(6):366-70. PubMed ID: 22992402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients.
    Florindez J; Trent J
    Am J Clin Oncol; 2020 Apr; 43(4):270-278. PubMed ID: 31904710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.
    Hølmebakk T; Bjerkehagen B; Hompland I; Stoldt S; Boye K
    Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of positive microscopic margins (R1 resection) in patients with GIST (gastrointestinal stromal tumours): Results of a multicenter European study.
    Thibaut F; Veziant J; Warlaumont M; Gauthier V; Lefèvre J; Gronnier C; Bonnet S; Mabrut JY; Regimbeau JM; Benhaim L; Tiberio GAM; Mathonnet M; Regenet N; Chirica M; Glehen O; Mariani P; Panis Y; Genser L; Mutter D; Théreaux J; Bergeat D; Le Roy B; Brigand C; Eveno C; Guillaume P;
    Eur J Surg Oncol; 2024 Jun; 50(6):108310. PubMed ID: 38598874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs).
    Åhlén J; Karlsson F; Wejde J; Nilsson IL; Larsson C; Bränström R
    World J Surg; 2018 Aug; 42(8):2512-2521. PubMed ID: 29435627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.